← Leaderboards
Cornelis P Terhorst
Beth Israel Deaconess Medical Center
$22,963,281
Attributed
$26,819,955
Total exposure
19
Grants
13
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $5.4M · FY2005–24$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$59,724,717 · 22
By mechanism
P01$40,793,639 · 12
R01$17,191,086 · 4
R21$856,080 · 2
R56$317,450 · 1
R37$257,808 · 1
P30$188,750 · 1
Top collaborators
- Ype Peter De Jong8 shared
- Roland W. Herzog8 shared
Most similar at Beth Israel Deaconess Medical Center
Same institution · by research overlap
- Ninghai Wang$1,759,755
Others in their field
Top investigators on “Research Study”
- David Heimbrook · Leidos Biomedical Research, Inc.$876,439,260
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Jeffrey P Krischer · University Of South Florida$605,922,209
- Lawrence Corey · Fred Hutchinson Cancer Center$605,141,231
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$512,975,910
Research focus
Research StudyReceptorPathway InteractionsCellsImmune ResponsePathogenesisT-LymphocyteLigandsAffectDesignBaseMonoclonal AntibodiesProductionProgramsDendritic CellsAntigensCd4 Positive T LymphocytesImmuneResearch PersonnelLeadGeneticSignal TransductionResponseCell Physiology
Grant awards (109)
Enhancing immune regulation in gene therapy for hemophilia$704,157
R01 · FY2024 · HL
Enhancing immune regulation in gene therapy for hemophilia$724,174
R01 · FY2023 · HL
Enhancing immune regulation in gene therapy for hemophilia$729,657
R01 · FY2022 · HL
Enhancing immune regulation in gene therapy for hemophilia$761,303
R01 · FY2021 · HL
Enhancing immune regulation in gene therapy for hemophilia$696,357
R01 · FY2019 · HL
Enhancing immune regulation in gene therapy for hemophilia$708,753
R01 · FY2018 · HL
Enhancing immune regulation in gene therapy for hemophilia$715,056
R01 · FY2017 · HL
SLAM Gene Family Controlled Pathways to SLE$1,610,772
P01 · FY2016 · AI · contact PI
Enhancing immune regulation in gene therapy for hemophilia$745,554
R01 · FY2016 · HL
The Slamf3, Slamf5, and Slamf6 receptor-induced pathways to murine lupus$350,959
P01 · FY2016 · AI · contact PI
Administrative Core$66,447
P01 · FY2016 · AI · contact PI
SLAM Gene Family Controlled Pathways to SLE$1,610,773
P01 · FY2015 · AI · contact PI
The Slamf3, Slamf5, and Slamf6 receptor-induced pathways to murine lupus$350,240
P01 · FY2015 · AI · contact PI
Administrative Core$66,313
P01 · FY2015 · AI · contact PI
SLAM Gene Family Controlled Pathways to SLE$1,610,772
P01 · FY2014 · AI · contact PI
The Slamf3, Slamf5, and Slamf6 receptor-induced pathways to murine lupus$350,239
P01 · FY2014 · AI · contact PI
Administrative Core$66,313
P01 · FY2014 · AI · contact PI
Primary Immuno-Deficiencies Affecting Specific Stages of the Immune Response$1,733,667
P01 · FY2013 · AI · contact PI
SLAM Gene Family Controlled Pathways to SLE$1,514,125
P01 · FY2013 · AI · contact PI
The Slamf3, Slamf5, and Slamf6 receptor-induced pathways to murine lupus$1,103,333
P01 · FY2013 · AI · contact PI
Study of LY108 innate and adaptive immune responses$344,929
R01 · FY2013 · DK · contact PI
Cell Surface Receptors on T Cells and Macrophages$317,450
R56 · FY2013 · AI · contact PI
Role of SAP (SH2D1A) gene in T cell-dependent antibody response$272,566
P01 · FY2013 · AI · contact PI
Administrative Core$51,134
P01 · FY2013 · AI · contact PI
Administrative Core$43,068
P01 · FY2013 · AI · contact PI
Primary Immuno-Deficiencies Affecting Specific Stages of the Immune Response$1,808,155
P01 · FY2012 · AI · contact PI
SLAM Gene Family Controlled Pathways to SLE$1,646,962
P01 · FY2012 · AI · contact PI
Pathways to Inflammatory Bowel Disease$374,889
R01 · FY2012 · DK · contact PI
Study of LY108 innate and adaptive immune responses$357,440
R01 · FY2012 · DK · contact PI
The Slamf3, Slamf5, and Slamf6 receptor-induced pathways to murine lupus$357,136
P01 · FY2012 · AI · contact PI
Role of SAP (SH2D1A) gene in T cell-dependent antibody response$284,214
P01 · FY2012 · AI · contact PI
Administrative Core$67,031
P01 · FY2012 · AI · contact PI
Administrative Core$44,979
P01 · FY2012 · AI · contact PI
Primary Immuno-Deficiencies Affecting Specific Stages of the Immune Response$1,808,883
P01 · FY2011 · AI · contact PI
Cell Surface Receptors on T cells and Macrophages$408,629
R01 · FY2011 · AI · contact PI
Pathways to Inflammatory Bowel Disease$374,889
R01 · FY2011 · DK · contact PI
Study of LY108 innate and adaptive immune responses$357,440
R01 · FY2011 · DK · contact PI
Role of SAP (SH2D1A) gene in T cell-dependent antibody response$292,369
P01 · FY2011 · AI · contact PI
Administrative Core$80,308
P01 · FY2011 · AI · contact PI
Primary Immuno-Deficiencies Affecting Specific Stages of the Immune Response$1,813,883
P01 · FY2010 · AI · contact PI
SLAM Gene Family Controlled Pathways to SLE$1,347,828
P01 · FY2010 · AI · contact PI
Study of LY108 innate and adaptive immune responses$434,375
R01 · FY2010 · DK · contact PI
Cell Surface Receptors on T cells and Macrophages$412,757
R01 · FY2010 · AI · contact PI
Pathways to Inflammatory Bowel Disease$378,675
R01 · FY2010 · DK · contact PI
Role of SAP (SH2D1A) gene in T cell-dependent antibody response$296,116
P01 · FY2010 · AI · contact PI
Genetic Dissection of the defect in the SLAM-receptor.........$282,338
P01 · FY2010 · AI · contact PI
Administrative Core$81,541
P01 · FY2010 · AI · contact PI
Administrative Core$41,614
P01 · FY2010 · AI · contact PI
Primary Immuno-Deficiencies Affecting Specific Stages of the Immune Response$1,822,109
P01 · FY2009 · AI · contact PI
SLAM Gene Family Controlled Pathways to SLE$1,325,711
P01 · FY2009 · AI · contact PI
Cell Surface Receptors on T cells and Macrophages$416,925
R01 · FY2009 · AI · contact PI
Pathways to Inflammatory Bowel Disease$382,500
R01 · FY2009 · DK · contact PI
IMMUNE$354,931
P01 · FY2009 · HL · contact PI
Role of SAP (SH2D1A) gene in T cell-dependent antibody response$300,968
P01 · FY2009 · AI · contact PI
Genetic Dissection of the defect in the SLAM-receptor.........$278,445
P01 · FY2009 · AI · contact PI
Administrative Core$90,497
P01 · FY2009 · AI · contact PI
Administrative Core$41,267
P01 · FY2009 · AI · contact PI
SLAM Gene Family Controlled Pathways to SLE$1,289,925
P01 · FY2008 · AI · contact PI
Cell Surface Receptors on T cells and Macrophages$416,925
R01 · FY2008 · AI · contact PI
Pathways to Inflammatory Bowel Disease$382,500
R01 · FY2008 · DK · contact PI
Study of Ly108 induced innate and adaptive immune responses$283,096
R01 · FY2008 · DK · contact PI
Genetic Dissection of the defect in the SLAM-receptor.........$271,604
P01 · FY2008 · AI · contact PI
IMMUNE$270,095
P01 · FY2008 · HL · contact PI
Administrative Core$40,475
P01 · FY2008 · AI · contact PI
SLAM Gene Family Controlled Pathways to SLE$1,318,446
P01 · FY2007 · AI · contact PI
Models of Human Immunodeficiencies$1,309,648
P01 · FY2007 · AI · contact PI
Cell Surface Receptors on T cells and Macrophages$425,000
R01 · FY2007 · AI · contact PI
Pathways to Inflammatory Bowel Disease$378,799
R01 · FY2007 · DK · contact PI
Study of Ly108 induced innate and adaptive immune responses$288,873
R01 · FY2007 · DK · contact PI
IMMUNE$269,956
P01 · FY2007 · HL · contact PI
Genetic Dissection of the defect in the SLAM-receptor.........$259,028
P01 · FY2007 · AI · contact PI
Administrative Core$32,638
P01 · FY2007 · AI · contact PI
SLAM Gene Family Controlled Pathways to SLE$1,391,444
P01 · FY2006 · AI · contact PI
Models of Human Immunodeficiencies$1,311,051
P01 · FY2006 · AI · contact PI
Cell Surface Receptors on T Cells and Macrophages$415,013
R01 · FY2006 · AI · contact PI
Pathways to Inflammatory Bowel Disease$390,113
R01 · FY2006 · DK · contact PI
Study Ly108 induced innate and adaptive immune response$297,500
R01 · FY2006 · DK · contact PI
IMMUNE$272,049
P01 · FY2006 · HL · contact PI
Genetic Dissection of the defect in the SLAM-receptor.........$263,546
P01 · FY2006 · AI · contact PI
GENETIC ANIMAL MODEL CORE$188,750
P30 · FY2006 · DK · contact PI
Administrative Core$79,689
P01 · FY2006 · AI · contact PI
Models of Human Immunodeficiencies$1,308,282
P01 · FY2005 · AI
Cell Surface Receptors on T Cells and Macrophages$425,000
R01 · FY2005 · AI
Pathways to Inflammatory Bowel Disease$399,500
R01 · FY2005 · DK
IMMUNE$239,144
P01 · FY2005 · HL
Control of signaling of SLAM receptors in dendritic cell$39,968
R03 · FY2005 · TW
Models of Human Immunodeficiencies$1,274,973
P01 · FY2004 · AI
Cell Surface Receptors on T Cells and Macrophages$425,000
R01 · FY2004 · AI
Pathways to Inflammatory Bowel Disease$399,500
R01 · FY2004 · DK
Control of signaling of SLAM receptors in dendritic cell$39,968
R03 · FY2004 · TW
Models of Human Immunodeficiencies$658,233
P01 · FY2003 · AI
Cell Surface Receptors on T Cells and Macrophages$425,000
R01 · FY2003 · AI
Pathways to Inflammatory Bowel Disease$399,500
R01 · FY2003 · DK
Control of signaling of SLAM receptors in dendritic cell$39,968
R03 · FY2003 · TW
MODELS OF HUMAN IMMUNODEFICIENCIES$1,162,179
P01 · FY2002 · AI
Cell Surface Receptors on T Cells and Macrophages$425,000
R01 · FY2002 · AI
Biochemical Studies of Human Cell Surface Markers$340,000
R21 · FY2002 · AI
ROLE OF THE XLP GENE, SAP, IN T CELL FUNCTIONS$0
P01 · FY2002 · AI
MODELS OF HUMAN IMMUNODEFICIENCIES$1,129,386
P01 · FY2001 · AI
REGULATION OF T CELL RESPONSES IN IBD$261,000
R21 · FY2001 · AI
PATHWAYS TO INFLAMMATORY BOWEL DISEASE$257,113
R01 · FY2001 · DK
CELL SURFACE RECEPTORS ON CYTOTOXIC T CELLS$239,784
R01 · FY2001 · AI
ROLE OF THE XLP GENE, SAP, IN T CELL FUNCTIONS$0
P01 · FY2001 · AI
MODELS OF HUMAN IMMUNODEFICIENCIES$1,097,555
P01 · FY2000 · AI
ROLE OF THE XLP GENE, SAP, IN T CELL FUNCTIONS$276,287
P01 · FY2000 · AI
BIOCHEMICAL STUDIES OF HUMAN CELLS SURFACE MARKERS$257,808
R37 · FY2000 · AI
REGULATION OF T CELL RESPONSES IN IBD$255,080
R21 · FY2000 · AI
PATHWAYS TO INFLAMMATORY BOWEL DISEASE$249,627
R01 · FY2000 · DK
CELL SURFACE RECEPTORS ON CYTOTOXIC T CELLS$239,784
R01 · FY2000 · AI